|Articles|August 7, 2012
Mark Zitter, MBA, Discusses Oncology Pathways
Mark Zitter, MBA, CEO of the Zitter Group, states that oncology pathways can standardize the way care is delivered while improving quality and reducing costs.
Advertisement
Mark Zitter, MBA, CEO of the Zitter Group, states that oncology pathways can standardize the way care is delivered while improving quality and reducing costs. However, Zitter says that over the next year or so, pathways will not be the dominant factor in oncology management.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FAQs: FDA Lawsuit Challenges E-Cigarette Enforcement Policy, PMTA Guidance
2
Cognitive Rehabilitation Improves Functional Outcomes in Long COVID Brain Fog
3
Active US Drug Shortages Rise for Third Straight Quarter
4
Tec-Dara Closes Survival Gap in High-Risk MM: Rahul Banerjee, MD
5